Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NEM | XOM |
|---|---|---|
| Price | $120.74 | $162.51 |
| Change today | ▼ 2.27% | ▲ 0.79% |
| Market cap | $127.22B | $668.23B |
| Return, 3 months | +28.7% | +19.5% |
| Return, year to date | +21.7% | +37.8% |
| Return, 1 year | +46.0% | +46.0% |
| P/E (TTM) | 15.2 | 20.9 |
| P/B | 3.6 | 2.6 |
| P/E percentile vs own 5y | 61st | 90th |
| Dividend yield | 0.84% | 2.51% |
| Revenue growth (YoY, latest qtr) | +15.1% | +44.1% |
| Net profit growth (YoY) | +8.5% | +102.4% |
| Gross margin | 59.1% | 20.6% |
| Operating margin | 55.2% | 10.7% |
| Net margin | 33.4% | 9.1% |
| Return on equity | 25.5% | 12.6% |
| Analyst target vs. price | +14.1% | +4.7% |
| Analyst buy share | 92% | 50% |
| RSI (14) | 50 | 51 |
| 30-day volatility | 43.7% | 25.7% |
| Max drawdown, 1 year | -32.1% | -20.1% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.